Acasă › Cancer metastatic › Minnesota › Rochester
Studii clinice pentru Cancer metastatic în Rochester, MN
31 studii pentru Cancer metastatic caută participanți în și în jurul orașului Rochester (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
În curs de recrutareFaza 2
- Mayo Clinic in Rochester, Rochester
Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors
În curs de recrutare
- Mayo Clinic in Rochester, Rochester
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
În curs de recrutareFaza 2
- Mayo Clinic in Rochester, Rochester
PRE-ISPY Phase I/II Oncology Platform Program
În curs de recrutareFaza 1/2
- Mayo Clinic Comprehensive Cancer Center, Rochester
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
În curs de recrutareFaza 2/3
- Mayo Clinic, Rochester
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
În curs de recrutareFaza 3
- Mayo Clinic Hospital, Methodist Campus, Research Pharmacy, Rochester
- Mayo Clinic Pharmacy, Rochester
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- și încă 3
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
În curs de recrutareFaza 1
- Mayo Clinic Rochester, Rochester
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
În curs de recrutareFaza 2
- Mayo Clinic Cancer Center, Rochester
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
În curs de recrutareFaza 2/3
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
În curs de recrutareFaza 3
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
În curs de recrutareFaza 3
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
În curs de recrutareFaza 2
- Mayo Clinic Rochester, Rochester
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
În curs de recrutareFaza 1/2
- Mayo Clinic Hospital, Methodist Campus, Research Pharmacy, Rochester
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
CREO - Microwave Ablation Feasibility Study
În curs de recrutare
- Mayo Clinic Rochester, Rochester
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
În curs de recrutareFaza 1
- Mayo Clinic in Rochester, Rochester
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
În curs de recrutareFaza 3
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
În curs de recrutareFaza 1
- Mayo Clinic - Rochester, Rochester
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
În curs de recrutareFaza 2
- Research Site, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- Mayo Clinic, Rochester
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
În curs de recrutareFaza 1/2
- Crinetics Study Site, Rochester
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- Mayo Clinic (Minnesota), Rochester
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
În curs de recrutareFaza 1
- Mayo Clinic, Rochester
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
În curs de recrutareStudiu observațional
- Mayo Clinic in Rochester, Rochester
Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients
În curs de recrutare
- Mayo Clinic in Rochester, Rochester
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
În curs de recrutareStudiu observațional
- Mayo Clinic in Rochester, Rochester
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
În curs de recrutareFaza 2/3
- Mayo Clinic Comprehensive Cancer Center, Rochester
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
În curs de recrutareFaza 2/3
- Mayo Clinic Rochester, Rochester
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
În curs de recrutareStudiu observațional
- Mayo Clinic in Rochester, Rochester
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
În curs de recrutareFaza 3
- Mayo Clinic - Rochester, Mn, Rochester
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Mayo Clinic, Rochester
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
În curs de recrutareFaza 1/2
- Mayo Clinic in Minnesota, Rochester
Studii pentru Cancer metastatic în alte orașe
- Houston, TX104 studii
- New York City, NY93 studii
- Nashville, TN70 studii
- Boston, MA63 studii
- Los Angeles, CA57 studii
- St. Louis, MO54 studii
- Arlington, VA53 studii
- Philadelphia, PA46 studii
- Chicago, IL45 studii
- San Antonio, TX44 studii
- Washington, DC43 studii
- Dallas, TX42 studii
Alte studii în Rochester
- Cancer de sân42 studii
- Cancer pulmonar cu celule non-pătrate37 studii
- Cancer (toate tipurile)30 studii
- Cancer ovarian29 studii
- Cancer colorectal29 studii
- Mielom multiplu24 studii
- Insuficiență cardiacă22 studii
- Cancer de prostată22 studii
- Cancer pancreatic22 studii
- Cancer endometrial20 studii
- Cancer pulmonar20 studii
- Leucemie limfatică cronică18 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.